Osborne Partners Capital Management’s Elevance Health ELV Stock Holding History

Osborne Partners Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-497	Closed	-$258K	–	219
2024 Q3	$258K	Hold	497	–	–	0.01%	203
2024 Q2	$269K	Hold	497	–	–	0.02%	192
2024 Q1	$258K	Sell	497 -80	-14%	-$39.8K	0.02%	182
2023 Q4	$272K	Buy	+577	New	+$267K	0.02%	188
2023 Q3	–	Sell	-561	Closed	-$249K	–	201
2023 Q2	$249K	Hold	561	–	–	0.02%	189
2023 Q1	$258K	Buy	+561	New	+$267K	0.02%	188

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Osborne Partners Capital Management's ELV Position: Q4 2024 in Review

Osborne Partners Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 497 shares — an estimated $258K sold.

Osborne Partners Capital Management first reported a position in ELV in Q1 2023 and held it in 6 quarters. The position peaked at $272K in Q4 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Osborne Partners Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Osborne Partners Capital Management sold 497 Elevance Health shares in Q4 2024, an estimated $258K.
Osborne Partners Capital Management first reported a position in Elevance Health in Q1 2023 and held it in 6 quarters.
Osborne Partners Capital Management's Elevance Health position peaked at $272K in Q4 2023.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Osborne Partners Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.